Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Peripheral T-cell lymphomas (PTCLs) are aggressive cancers with limited treatment options.
• The T-cell receptor (TCR) signaling pathway plays a crucial role in T-cell function and is frequently dysregulated in PTCLs.
• Ras- and Rho-family GTPases are key regulators of cellular signaling, including TCR pathways.

Purpose of the Study:

• To review the role of GTPases in TCR signaling within the context of PTCLs.
• To highlight the spectrum of mutations affecting GTPases in PTCL subtypes.
• To discuss the functional consequences of these mutations and their therapeutic implications.

Main Methods:

• Literature review of studies investigating TCR signaling pathway mutations in PTCLs.
• Analysis of genetic alterations in GTPases and associated signaling molecules.
• Examination of the functional impact of identified mutations on T-cell signaling.

Main Results:

• Mutations in GTPases, including VAV1, KRAS, and RHOA, are recurrent in PTCLs.
• These mutations can be activating, dominant-negative, or involve gene fusions.
• Dysregulation of TCR signaling through genes like CD28, FYN, LCK, and PLCG1 also impacts GTPase activity in PTCLs.

Conclusions:

• Mutations within the TCR signaling pathway, particularly those affecting Ras- and Rho-family GTPases, are a significant feature of PTCLs.
• These genetic alterations provide potential targets for novel therapeutic strategies.
• Further research into these pathways may lead to improved treatment outcomes for PTCL patients.